Activins and related proteins in the establishment of pregnancy

Reproductive Sciences

Volumn 17, Issue 4, 2010, Pages 320-330

  Florio, Pasquale ^a   Gabbanini, Massimo ^a   Borges, Lavinia E ^a   Bonaccorsi, Lorella ^a   Pinzauti, Serena ^a   Reis, Fernando M ^a   Boy Torres, Paulo ^a   Rago, Giuseppe ^a   Litta, Pietro ^b   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Abortion; Activin A; Decidualization; Ectopic pregnancy; Embryo implantation; Endometrium; Miscarriage; Pregnancy

Indexed keywords

ACTIVIN A; ENDOMETRIAL BLEEDING ASSOCIATED FACTOR; FOLLISTATIN; FOLLISTATIN RELATED PROTEIN; INHIBIN; LEUKEMIA INHIBITORY FACTOR; MATRIX METALLOPROTEINASE; PROGESTERONE; PROTEIN; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CELL DIFFERENTIATION; CYTOTROPHOBLAST; DECIDUALIZATION; ECTOPIC PREGNANCY; ENDOMETRIUM CELL; HUMAN; IMPLANTATION; INCOMPLETE ABORTION; NIDATION; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECURRENT ABORTION; REVIEW;

ACTIVINS; EMBRYO IMPLANTATION; FEMALE; FOLLISTATIN; HUMANS; INHIBINS; LEFT-RIGHT DETERMINATION FACTORS; LEUKEMIA INHIBITORY FACTOR; MATRIX METALLOPROTEINASES; PREGNANCY; PREGNANCY COMPLICATIONS; PROGESTERONE;

EID: 77949370959     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719109353205     Document Type: Review

References (81)

1. Jabbour HN, Kelly RW, Fraser HM, Critchley HO Endocrine regulation of menstruation. Endocr Rev. 2006 ; 27 (1). 17-46.
2. Gargett CE, Chan RW, Schwab KE Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol Cell Endocrinol. 2008 ; 288 (1-2). 22-29.
3. Guzeloglu-Kayisli O., Basar M., Arici A. Basic aspects of implantation. Reprod Biomed Online. 2007 ; 15 (6). 728-739.
4. Gellersen B., Brosens IA, Brosens JJ Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med. 2007 ; 25 (6). 445-453.
5. Reis FM, Cobellis L., Luisi S., et al. Paracrine/autocrine control of female reproduction. Gynecol Endocrinol. 2000 ; 14 (6). 464-475.
6. Florio P., Rossi M., Sigurdardottir M., et al. Paracrine regulation of endometrial function: interaction between progesterone and corticotropin- releasing factor (CRF) and activin A. Steroids. 2003 ; 68 (10-13). 801-807.
7. Salamonsen LA, Dimitriadis E., Jones RL, Nie G. Complex regulation of decidualization: a role for cytokines and proteases-a review. Placenta. 2003 ; 24 (suppl A). S76 - S85.
8. Luisi S., Florio P., Reis FM, Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol. 2001 ; 145 (3). 225-236.
9. Guo X., Wang XF Signaling cross-talk between TGF-beta/ BMP and other pathways. Cell Res. 2008 ; 19 (1). 71-88.
10. Lin SJ, Lerch TF, Cook RW, Jardetzky TS, Woodruff TK The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction. 2006 ; 132 (2). 179-190.
11. Chang H., Brown CW, Matzuk MM Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev. 2002 ; 23 (6). 787-823.
12. Welt C., Sidis Y., Keutmann H., Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med. 2002 ; 227 (9). 724-752.
13. Derynck R., Zhang Y., Feng XH Smads: transcriptional activators of TGF-b responses. Cell. 1998 ; 95 (6). 737-740.
14. Harrison CA, Gray PC, Vale WW, Robertson DM Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab. 2005 ; 16 (2). 73-78.
15. Schneyer AL, Wang Q., Sidis Y., Sluss PM Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab. 2004 ; 89 (10). 5067-5075.
16. Shimonaka M., Inouye S., Shimasaki S., Ling N. Follistatin binds to both activin and inhibin through the common subunit. Endocrinology. 1991 ; 128 (6). 3313-3315.
17. Tsuchida K., Arai KY, Kuramoto Y., Yamakawa N., Hasegawa Y., Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem. 2000 ; 275 (52). 40788-40796.
18. Schneyer A., Schoen A., Quigg A., Sidis Y. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology. 2003 ; 144 (5). 1671-1674.
19. Bilezikjian LM, Blount AL, Donaldson CJ, Vale WW Pituitary actions of ligands of the TGF-beta family: activins and inhibins. Reproduction. 2006 ; 132 (2). 207-215.
20. Chapman SC, Bernard DJ, Jelen J., Woodruff TK Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Mol Cell Endocrinol. 2002 ; 196 (1-2). 79-93.
21. Lewis KA, Gray PC, Blount AL, et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature. 2000 ; 404 (6776). 411-414.
22. Kosaki K., Bassi MT, Kosaki R., et al. Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. Am J Hum Genet. 1999 ; 64 (3). 712-721.
23. Ulloa L., Tabibzadeh SJ Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor. Biol Chem. 2001 ; 276 (24). 21397-21404.
24. Ling N., Ying SY, Ueno N., et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature. 1986 ; 321 (6072). 779-782.
25. Florio P., Severi FM, Luisi S., et al. Endometrial expression and secretion of activin A, but not follistatin, increase in the secretory phase of the menstrual cycle. J Soc Gynecol Investig. 2003 ; 10 (4). 237-243.
26. Petraglia F., Florio P., Luisi S., et al. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J Clin Endocrinol Metab. 1998 ; 83 (4). 1194-1200.
27. Reis FM, Di Blasio AM, Florio P., Ambrosini G., Di Loreto C., Petraglia F. Evidence for local production of inhibin A and activin A in patients with ovarian endometriosis. Fertil Steril. 2001 ; 75 (2). 367-373.
28. Leung PH, Salamonsen LA, Findlay JK Immunolocalization of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum Reprod. 1998 ; 13 (12). 3469-3477.
29. Otani T., Minami S., Kokawa K., Shikone T., Yamoto M., Nakano R. Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol. 1998 ; 91 (5 pt 1). 685-692.
30. Morrish DW, Dakour J., Li H. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue. Functional regulation of human trophoblast differentiation. J Reprod Immunol. 1998 ; 39 (1-2). 179-195.
31. Mylonas I., Makovitzky J., Hoeing A., et al. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue. Acta Histochem. 2006 ; 108 (1). 1-11.
32. Mylonas I., Jeschke U., Wiest I., et al. Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol. 2004 ; 122 (5). 461-471.
33. Teni TR, Sampat MB, Sheth NA Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study. J Pathol. 1992 ; 168 (1). 35-40.
34. Petraglia F., Calzã L., Garuti GC, et al. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab. 1990 ; 71 (2). 487-492.
35. Worbs S., Shabani N., Mayr D., et al. Expression of the inhibin/ activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers. Oncol Rep. 2007 ; 17 (1). 97-104.
36. Mylonas I., Jeschke U., Winkler L., et al. Immunohistochemical expression of inhibin-alpha in human endometrium and the in vitro secretion of inhibin, estradiol and cortisol in cultured human endometrial glandular cells. Arch Gynecol Obstet. 2003 ; 268 (3). 142-150.
37. Florio P., Ciarmela P., Reis FM, et al. Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma. Eur J Endocrinol. 2005 ; 152 (2). 277-284.
38. Torres PB, Florio P., Ferreira MC, Torricelli M., Reis FM, Petraglia F. Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis. Fertil Steril. 2007 ; 88 (1). 200-205.
39. Jones RL, Salamonsen LA, Zhao YC, Ethier JF, Drummond AE, Findlay JK Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization. Mol Hum Reprod. 2002 ; 8 (4). 363-374.
40. Petraglia F., Gallinelli A., Grande A., et al. Local production and action of follistatin in human placenta. J Clin Endocrinol Metab. 1994 ; 78 (1). 205-210.
41. Wang HQ, Takebayashi K., Tsuchida K., Nishimura M., Noda Y. Follistatin-related gene (FLRG) expression in human endometrium: sex steroid hormones regulate the expression of FLRG in cultured human endometrial stromal cells. J Clin Endocrinol Metab. 2003 ; 88 (9). 4432-4439.
42. Florio P., Ciarmela P., Toti P., et al. Human endometrium and decidua express follistatin-related gene (FLRG) mRNA and peptide. Mol Cell Endocrinol. 2004 ; 218 (1-2). 129-135.
43. Tabibzadeh S., Lessey B., Satyaswaroop PG Temporal and site-specific expression of transforming growth factor-b4 in human endometrium. Mol Hum Reprod. 1998 ; 4 (6). 595-602.
44. Cornet PB, Picquet C., Lemoine P., et al. Regulation and function of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progesterone, and effect on matrix metalloprotineases. Biol Chem. 2002 ; 277 (45). 42496-42504.
45. Tang M., Mikhailik A., Pauli I., et al. Decidual differentiation of stromal cells promotes Proprotein Convertase 5/6 expression and lefty processing. Endocrinology. 2005 ; 146 (12). 5313-5320.
46. Piestrzeniewicz-Ulanska D., Brys M., Semczuk A., Jakowicki JA, Krajewska WM Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium. Cancer Lett. 2002 ; 186 (2). 231-239.
47. Gellersen B., Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol. 2003 ; 178 (3). 357-372.
48. Jones RL, Findlay JK, Salamonsen LA The role of activins during decidualisation of human endometrium. Aust N Z J Obstet Gynaecol. 2006 ; 46 (3). 245-249.
49. Jones RL, Salamonsen LA, Findlay JK. Activin A promotes human endometrial stromal cell decidualization in vitro. J Clin Endocrinol Metab. 2002 ; 87 (8). 4001-4004.
50. Florio P., Rossi M., Viganï P., et al. Interleukin 1beta and progesterone stimulate activin a expression and secretion from cultured human endometrial stromal cells. Reprod Sci. 2007 ; 14 (1). 29-36.
51. Telgmann R., Gellersen B. Marker genes of decidualization: activation of the decidual prolactin gene. Hum Reprod Update. 1998 ; 4 (5). 472-479.
52. Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E., Salamonsen LA Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology. 2006 ; 147 (2). 724-732.
53. Tierney EP, Giudice LC Role of activin A as a mediator of in vitro endometrial stromal cell decidualization via the cyclic adenosine monophosphate pathway. Fertil Steril. 2004 ; 81 (suppl 1). 899-903.
54. Harada M., Osuga Y., Takemura Y., et al. Mechanical stretch upregulates IGFBP-1 secretion from decidualized endometrial stromal cells. Am J Physiol Endocrinol Metab. 2006 ; 290 (2). E268 - E272.
55. Curry TE, Osteen KG The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev. 2003 ; 24 (4). 428-465.
56. Zhang X., Nothnick WB The role and regulation of the uterine matrix metalloproteinase system in menstruating and non-menstruating species. Front Biosci. 2005 ; 10: 353-366.
57. Salamonsen LA, Woolley DE Matrix metalloproteinases in normal menstruation. Hum Reprod. 1996 ; 11 (suppl 2). 124-133.
58. Paria BC, Song H., Dey SK Implantation: molecular basis of embryo-uterine dialogue. Int J Dev Biol. 2001 ; 45 (3). 597-605.
59. Dimitriadis E., White CA, Jones RL, Salamonsen LA Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update. 2005 ; 11 (6). 613-630.
60. Domínguez F., Remohí J., Pellicer A., Simón C. Paracrine interactions during human implantation. Rev Endocr Metab Disord. 2002 ; 3 (2). 97-105.
61. Rossi M., Sharkey AM, Viganï P., et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction. 2005 ; 130 (5). 721-729.
62. Tabibzadeh S. Molecular control of the implantation window. Hum Reprod Update. 1998 ; 4 (5). 465-471.
63. Kashiwagi A., DiGirolamo CM, Kanda Y., et al. The postimplantation embryo differentially regulates endometrial gene expression and decidualization. Endocrinology. 2007 ; 148 (9). 4173-4184.
64. Sunder S., Lenton EA Endocrinology of the peri-implantation period. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000 ; 14 (5). 789-800.
65. Keelan JA, Groome NP, Mitchell MD Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines. Placenta. 1998 ; 19 (5-6). 429-434.
66. Perrier d'Hauterive S., Charlet-Renard C., Dubois M., et al. Human endometrial leukemia inhibitory factor and interleukin-6: control of secretion by transforming growth factor-beta-related members. Neuroimmunomodulation. 2005 ; 12 (3). 157-163.
67. Bearfield C., Jauniaux E., Groome N., Sargent IL, Muttukrishna S. The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro. Eur J Endocrinol. 2005 ; 152 (6). 909-916.
68. Caniggia I., Lye SJ, Cross JC Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology. 1997 ; 138 (9). 3976-3986.
69. Jones RL, Salamonsen LA, Findlay JK Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy. Trends Endocrinol Metab. 2002 ; 13 (4). 144-150.
70. Tabibzadeh S., Mason JM, Shea W., Cai Y., Murray MJ, Lessey B. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab. 2000 ; 85 (7). 2526-2536.
71. Florio P., Bruni L., Galleri L., et al. Evaluation of endometrial activin A secretion for prediction of pregnancy after intrauterine insemination. Fertil Steril. 2009 Feb 5. [Epub ahead of print].
72. Prakash A., Tuckerman E., Laird S., Ola B., Li TC, Ledger WC A preliminary study comparing the endometrial expression of inhibin, activin and follistatin in women with a history of implantation failure after IVF treatment and a control group. BJOG. 2008 ; 115 (4). 532-537.
73. Refaat B., Amer S., Ola B., Chapman N., Ledge W. The expression of activin-A- and-B- subunits, follistatin, and activin type II receptors in fallopian tubes bearing an ectopic pregnancy. J Clin Endocrinol Metab. 2008 ; 93 (1). 293-299.
74. Florio P., Severi FM, Bocchi C., et al. Single serum activin a testing to predict ectopic pregnancy. J Clin Endocrinol Metab. 2007 ; 92 (5). 1748-1753.
75. Horne AW, van den Driesche S., King AE Endometrial inhibin/activin beta-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J Clin Endocrinol Metab. 2008 ; 93 (5). 2375-2382.
76. Florio P., Luisi S., Ciarmela P., Severi FM, Bocchi C., Petraglia F. Inhibins and activins in pregnancy. Mol Cell Endocrinol. 2004 ; 225 (1-2). 93-110.
77. Luisi S., Florio P., D'Antona D., et al. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. Eur J Endocrinol. 2003 ; 148 (2). 233-236.
78. Florio P., Luisi S., D'Antona D., Severi FM, Rago G., Petraglia F. Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertil Steril. 2004 ; 81 (2). 468-470.
79. Rai R., Regan L. Recurrent miscarriage. Lancet. 2006 ; 368 (9535). 601-611.
80. Prakash A., Laird S., Tuckerman E., Li TC, Ledger WL. Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril. 2005 ; 83 (6). 1758-1763.
81. Prakash A., Li TC, Tuckerman E., Laird S., Wells M., Ledger WL A study of luteal phase expression of inhibin, activin, and follistatin subunits in the endometrium of women with recurrent miscarriage. Fertil Steril. 2006 ; 86 (6). 1723-1730.